Abstract:The high prevalence of hypertension in China is well known, with stroke being the most common cause of death and disability. 1 GBD 2013 Mortality and Causes of Death CollaboratorsGlobal, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385: 117-171 Summary Full Text Full Text PDF PubMed Scopus (5370) Google Scholar Two large nationwide studies reported in The Lancet2 Lu J Lu Y Wang X et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017; (published online Oct 25.)http://dx.doi.org/10.1016/S0140-6736(17)32478-9 Summary Full Text Full Text PDF Scopus (567) Google Scholar , 3 Su M Zhang Q Bai X et al. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey. Lancet. 2017; (published online Oct 25.)http://dx.doi.org/10.1016/S0140-6736(17)32476-5 Summary Full Text Full Text PDF Scopus (82) Google Scholar highlight that although the prevalence of hypertension in China is similar to that suggested in previous studies, it is simple deficiencies in the country's health system that make a large contribution to the disease burden. Both studies used data from the PEACE (Patient-Centred Evaluative Assessment of Cardiac Events) Million Persons Project (MPP), which enrolled 1·7 million adults aged 35–75 years from across China. This is a population-centred, national screening initiative to detect populations at high risk of cardiovascular disease. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)Among Chinese adults aged 35–75 years, nearly half have hypertension, fewer than a third are being treated, and fewer than one in twelve are in control of their blood pressure. The low number of people in control is ubiquitous in all subgroups of the Chinese population and warrants broad-based, global strategy, such as greater efforts in prevention, as well as better screening and more effective and affordable treatment. Full-Text PDF Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional surveyChina has marked deficiencies in the availability, cost, and prescription of antihypertensive medications. High-value medications are not preferentially used. Future efforts to reduce the burden of hypertension, particularly through the work of primary health-care providers, will need to improve access to, and use of, antihypertensive medications, paying particular attention to those with high value. Full-Text PDF

Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension

Addressing Global Disparities in Blood Pressure Control: Perspectives of the International Society of Hypertension.

Mean systolic blood pressure above the control threshold in people with treated uncontrolled hypertension: a pooled, cross-sectional analysis of 55 national health surveys

Abstract 16828: Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies From 90 Countries

Prevalence, Treatment, and Control Rates of Conventional and Ambulatory Hypertension Across 10 Populations in 3 Continents

A Call to Action and a Lifecourse Strategy to Address the Global Burden of Raised Blood Pressure on Current and Future Generations: the Lancet Commission on Hypertension

Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension

Hypertension in Low- and Middle-Income Countries.

Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

Target Blood Pressure and Control Status in Asia

Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities: Results from the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases

Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: A 10/66 cross-sectional population-based survey

The global epidemiology of hypertension

World Heart Federation Roadmap for Hypertension – A 2021 Update

Hypertension in China: the Gap Between Policy and Practice

Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension

How to Improve Awareness, Treatment, and Control of Hypertension in Africa, and How to Reduce Its Consequences. A Call to Action From the World Hypertension League

Updated National and International Hypertension Guidelines: A Review of Current Recommendations

Agreement Regarding Overcoming Hypertension in the Asian Hypertension Society Network 2022

Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities